References
- AmarJVaurLPerretMon behalf of the PRATIK Study investigatorsHypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK Study)J Hypertens2002207798411910316
- AnsellBJWatsonKEFogelmanAMAn evidence-based assessment of the NCEP adult treatment panel II guidelinesJAMA199928220515710591388
- AvanziniFAlliCColomboPon behalf of the Physicians taking part in STAPControl of hypertension in Italy: results of the “Study on Antihypertensive Treatment in General Practice (STAP)”G Ital Cardiol19982876069773300
- BhattDLStegPGOhmanEMInternational prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisJAMA2006295180916403930
- BoumaMDekkerJHvan EiikJThMMetabolic control and morbidity of type 2 diabetic patients in a general practice networkFam Pract199916402610493712
- CamisascaPAvanziniFAlliCon behalf of the “Studio sul Trattamento Antipertensivo nella Pratica ambulatoriale (STAP)” participantsOverall cardiovascular risk still ignored in general practice care of hypertensionJ Cardiovasc Risk200291475212202837
- CannonPCBraunwaldEMcCabeCHIntensive versus moderate lipid lowering with statins after acute coronary sindromesN Engl J Med2004350149550415007110
- DunnNRBoughPStandards of care of diabetic patients in a typical English communityBr J Gen Pract19964640158776910
- EUROASPIRE II Study GroupLifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey ProgrammeEur Heart J2001225547211259143
- European Diabetes Policy GroupA desktop guide to type 2 diabetes mellitusDiabetic Med1999167163010510947
- FerrarioGAlkhimovitchOAvanziniFPeoples’ perception of their overall coronary risk: an Italian experienceItal Heart J20045162115080576
- GianpaoliSVanuzzoDItalian Atlas of Cardiovascular DiseasesItal Heart J200341st edSuppl 41S121S
- Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trialLancet200236072212114036
- Hippisley-CoxPringle MGeneral practice workload implications of the national service framework for coronary heart disease: cross sectional surveyBMJ20013232697011485958
- Lloyd-JonesDMEvansJCLarsonMGTreatment and control of hypertension in the community. A prospective analysisHypertension200240640612411456
- MoonJCSwitching statins. Using generic simvastatin as first line could save £2bn over five years in EnglandBMJ20063321344516763226
- PepineCJHandbergEMCooper-DeHoffRMA calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialJAMA200329028051614657064
- PilottoLGiaggioliALo NoceCIl diabete in Italia: un problema di sanità pubblicaItal Heart J Suppl20045480615471153
- PrimatestaPBrookesMPoulterNRImproved hypertension management and control: results from the heath survey for England 1998Hypertension2001388273211641294
- PrimatestaPPoulterNRLipid concentrations and the use of lipid-lowering drugs: evidence from a national cross-sectional surveyBMJ20003211322511090516
- PROGRESS Collaborative GroupRandomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackLancet200135810334111589932
- RoncaglioniMCAvanziniFRoccatagliataDHow general practitioners perceive and grade the cardiovascular risk of their patientsEur J Cardiovasc Prev Rehabil200411233815179106
- SleightPPouleurHZannadFBenefits, challenges, and registerability of the polypillEur Heart J2006271651–616603580
- UK Prospective Diabetes Study (UKPDS) GroupIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet1998352837539742976
- UK Prospective Diabetes Study (UKPDS) GroupEffect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)Lancet1998352854659742977
- WaldNJLawMRA strategy to reduce cardiovascular disease by more than 80%BMJ200332616
- WoodDDe BackerGFaergemanOtogether with members of the Task ForcePrevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEur Heart J199819143415039820987
- 1999 World Health Organization/International Society of Hypertension Guidelines for management of hypertensionJ Hypertens1999171518310067786